Back

Rakovina Therapeutics cuts Q2 net loss 41% to C$1.73 million

Verifying
  • Rakovina Therapeutics reported its Q2 2026 financial results and corporate developments.
  • C$1,727,748 was the Q2 2026 net loss, down approximately 41% year over year.
  • Rakovina completed a private-placement second tranche after reporting its Aug. 19 annual meeting results.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Rakovina Therapeutics cuts Q2 net loss 41% to C$1.73 million - CoinPost Terminal